Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 9/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 9/20 | 0.58 |
| ▸ | PRSS2 | P07478 | 9/20 | 0.58 |
| ▸ | PRSS3 | P35030 | 9/20 | 0.58 |
| ▸ | F2 | P00734 | 8/20 | 0.58 |
| ▸ | F9 | P00740 | 2/20 | 0.58 |
| ▸ | PROC | P04070 | 2/20 | 0.58 |
| ▸ | KLK1 | P06870 | 1/20 | 0.58 |
| ▸ | KLKB1 | P03952 | 11/20 | 0.57 |
| ▸ | CFH | P08603 | 1/20 | 0.57 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29286937 | 0.90 | KLKB1 (0.58) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL31678809 | 0.89 | KLKB1 (0.70) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL27536938 | 0.89 | KLKB1 (0.70) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL27519261 | 0.86 | F2 (0.58) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL27499211 | 0.86 | F2 (0.57) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL27499212 | 0.85 | F2 (0.56) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL27528955 | 0.82 | F2 (0.53) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL27500723 | 0.78 | F10 (0.57) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL27501129 | 0.78 | KLKB1 (0.57) | F10PRSS1PRSS2PRSS3F2 | |
| SCHEMBL3052253 | 0.73 | F10 (1.00) | F10PRSS1PRSS2PRSS3F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113307772-A | Human plasma kallikrein inhibitors | 拜奥克里斯特制药公司 | 2021-08-27 | — | — | CN | disclosed |